Park Avenue Institutional Advisers’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-628
Closed -$18K – 510
2016
Q1
$18K Sell
628
-22
-3% -$572 0.02% 498
2015
Q4
$20K Sell
650
-10
-2% -$328 0.02% 495
2015
Q3
$24K Sell
660
-16
-2% -$827 0.02% 497
2015
Q2
$39K Buy
+676
New +$34.5K 0.03% 465

Other funds holding THC

Park Avenue Institutional Advisers's THC Position: Q2 2016 in Review

Park Avenue Institutional Advisers sold out of Tenet Healthcare (THC) in Q2 2016, closing a stake of 628 shares — an estimated $18K sold.

Park Avenue Institutional Advisers first reported a position in THC in Q2 2015 and held it in 4 quarters. The position peaked at $39K in Q2 2015. 261 funds tracked by Wall St. Rank hold THC as of Q2 2016.

  • Park Avenue Institutional Advisers reported no remaining Tenet Healthcare position as of Q2 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 628 Tenet Healthcare shares in Q2 2016, an estimated $18K.
  • Park Avenue Institutional Advisers first reported a position in Tenet Healthcare in Q2 2015 and held it in 4 quarters.
  • Park Avenue Institutional Advisers's Tenet Healthcare position peaked at $39K in Q2 2015.
  • 261 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.